FindTrial
Sign In

Safety and Efficacy of Rapid ART Initiation in Chengdu HIV Patients: A Prospective Observational Study

Safety and Efficacy of Rapid ART Initiation in Chengdu HIV Patients: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600115993
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-09
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Interventions

Non-nucleoside Reverse Transcriptase Inhibitors Group:None
Integrase Group:None

Sponsors

Public Health Clinical Center of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. First confirmed HIV infection; 2. Never received ART; 3. Able to understand and sign the informed consent form; 4. Have good adherence and can cooperate with completing examinations and follow-ups during the study.

Exclusion criteria

Exclusion criteria: 1.Patients with unstable mental status or cognitive impairment; 2.Other conditions deemed by the investigator as unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
CD4+ T-lymphocyte count;HIV-RNA;—

Secondary

MeasureTime frame
Complete Blood Count;Liver Function Tests;Renal Function Tests;Lipid Profile;Hepatitis B;—

Countries

China

Contacts

Public ContactFan Hezhang

Public Health Clinical Center of Chengdu

1804062669@qq.com+86 28 6435 5023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026